CN Patent

CN111377985B — 化合物和缀合物及其制备方法和用途

Assigned to Suzhou Ruibo Biotechnology Co ltd · Expires 2023-11-10 · 3y expired

What this patent protects

一种可与寡核苷酸形成缀合物的化合物，该化合物具有如式(101)所示的结构。本公开还提供了相应的寡核苷酸缀合物。本公开的寡核苷酸缀合物能够特异性地靶向肝细胞，从而有效解决寡核苷酸药物的体内递送问题，毒性低，所递送的寡核苷酸具有高度的稳定性。

USPTO Abstract

一种可与寡核苷酸形成缀合物的化合物，该化合物具有如式(101)所示的结构。本公开还提供了相应的寡核苷酸缀合物。本公开的寡核苷酸缀合物能够特异性地靶向肝细胞，从而有效解决寡核苷酸药物的体内递送问题，毒性低，所递送的寡核苷酸具有高度的稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN111377985B
Jurisdiction
CN
Classification
—
Expires
2023-11-10
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Ruibo Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.